BIVI · ISSUER CIK 1580149
BIOVIE INC.
Between Aug 1, 2026 and Oct 29, 2026, 4 BIOVIE INC. insiders reported $49K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Do Cuong V (President & CEO, Director), with $32K.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$49KInsider buying
$0.00Insider selling
+$49KNet open-market
Aug 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 202621:01 | Aug 28, 2026 | BIVI | Chief Medical Officer | P · Buy | $2.16 | +4,843 | 6,036 | +406% | +$10K | -4.8% | -36.1% |
| Aug 28, 202621:01 | Aug 28, 2026 | BIVI | Director | P · Buy | $2.16 | +727 | 727 | New | +$2K | -4.8% | -36.1% |
| Aug 28, 202620:58 | Aug 28, 2026 | BIVI | Chief Financial Officer | P · Buy | $2.18 | +2,500 | 3,441 | +266% | +$5K | -4.0% | -36.7% |
| Aug 28, 202620:57 | Aug 27, 2026 | BIVI | President & CEO, Director | P · Buy | $2.08 | +15,210 | 16,117 | +1677% | +$32K | -8.4% | -33.7% |